Proximal Priority Versus Distal Priority Robotic Priming Effects in Patients With Chronic Stroke

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Jun 22, 2020

Keywords

ClinConnect Summary

This clinical trial is studying how different types of robotic therapy can help people who have had a stroke recover better use of their arms. Participants will be divided into two groups: one will focus on movements that are closer to the body, and the other will focus on movements that are farther away. Each participant will attend 18 therapy sessions over six weeks, where they will work with robotic devices designed to assist with arm movements. Researchers will evaluate participants' arm function at the beginning of the study, right after the therapy, and again three months later to see how well the treatments worked.

To be eligible for this study, participants should be between the ages of 20 and 75 and have had a stroke at least three months prior, resulting in moderate to severe difficulty using their affected arm. They should not have severe stiffness in their arm joints or any other serious health issues that could interfere with their participation. This study aims to find out which type of robotic therapy is more effective, and it could help improve rehabilitation techniques for stroke patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The inclusion criteria are age between 20 and 75 years old, more than 3 months after the onset of a first unilateral ischemic or hemorrhagic stroke, moderate to severe UE motor impairment (i.e., total UE score of the Fugl-Meyer Assessment \[FMA\] score between 18 and 56), no severe spasticity in any joints of the affected arm (modified Ashworth Scale score \<3 in any of the affected shoulder, elbow, wrist, and fingers), able to follow instructions (Mini-Mental State Examination total score \>24), no UE fractures in the past 3 months, and not simultaneously participating in other medication or rehabilitation studies.
• Exclusion Criteria:
• • The exclusion criteria are other neurologic, neuromuscular, or orthopedic disease, such as epilepsy, or severe health or physical conditions that might impede participation in this study.